pAAV-Vector-Dual-System-TBG-EGFP(CAT#: GTV-0426-YJ30)
Targeted at hepatocytes, this vector utilizes a promoter from a key transport protein. It delivers strong and lasting expression in the liver, making it a standard for systemic protein replacement and metabolic research with integrated help.
| Summary | |
|---|---|
| Application | Hepatic-specific expression |
| Related Diseases | Liver fibrosis; Cirrhosis |
| System Type | Dual System |
| Product Format | Single Plasmid |
| Size | 10 μg; 100 μg; 1 mg; 10 mg |
| Promoter | TBG |
| Transgene Reporter | EGFP |
| AAV Genome Type | ssAAV |
| Notice to Purchaser | For research use only. Not for use in diagnostic or therapeutic procedures. |
| Spe | |
|---|---|
| AAV Cassette | AAV-TBG-EGFP |
| ITRs | L-ITR (119 bp) + R-ITR (130 bp) |
| Plasmid Size | 10783 bp |
| Bacterial Resistance | Kana |
| Storage | Long-term storage: ≤ -20°C (Stable for at least 12 months). |
| Shipping | Dry ice. |
| Synonyms | pAAV-VDS-TBG-EGFP; pAAV-S2-TBG-EGFP; pVDS-TBG-EGFP |
